Exploiting APC Function as a Novel Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|1|90-102

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.1, 2014-01, pp. : 90-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy

By  

Current Gene Therapy, Vol. 12, Iss. 2, 2012-04 ,pp. : 77-91

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Targeted Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 4, 2004-06 ,pp. : 313-326

Bentham Science Publishers

Access to resources Recommend Favorite

Sipuleucel-T: APC 8015, APC-8015, Prostate Cancer Vaccine – Dendreon

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 3, 2006-01 ,pp. : 197-201

Adis International

Access to resources Recommend Favorite

Function and Antagonism of &bgr;

By  

Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. : 519-540

Bentham Science Publishers

Access to resources Recommend Favorite

14-3-3 zeta as novel molecular target for cancer therapy

By Matta Ajay   Siu KW Michael   Ralhan Ranju  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 515-523

Informa Healthcare

Access to resources Recommend Favorite